AstraZeneca · 1 month ago
Executive Director, Oncology Business Unit Strategy
US - Gaithersburg - MD
Full-time
Onsite
Director/Executive
$270K/yr - $405K/yr
10+ years expAstraZeneca is a leading biopharmaceutical company dedicated to advancing innovative therapies in oncology. The Executive Director for the Oncology Business Unit Strategy will lead the development and implementation of integrated oncology strategies, collaborating with R&D and senior leadership to drive impactful patient outcomes.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead development and implementation of therapy area, tumour, and indication strategies that align into a single, company‑wide oncology strategy with Oncology R&D and global franchise partners
Provide disciplined, insights‑driven valuations and strategic recommendations to C‑suite stakeholders to guide portfolio and investment decisions
Serve as the single point of contact and “single voice” for OBU tumor strategy, chairing bimonthly tumor forums and establishing best practices and transparent coverage across priority tumors (e.g., Breast, Lung)
Lead market research, forecasting, and insight generation to shape global brand strategies, R&D decisions, supply planning, and TA scenario analyses across multiple GPTs and assets
Produce rigorous, assumption‑based forecasts for all tumor pipeline assets through the annual cycle, clearly articulating risks, opportunities, and context for senior leaders
Drive clarity and consistency across key business processes (forecast reviews, investment cases, TA/portfolio reviews, business and audit reviews), including partnering with Finance VPs on annual impairment assessments
Integrate study designs, TPPs, CDPs, combination strategies, competitive and pricing landscapes, and stage‑specific disease strategies to inform prioritization and investment
Lead large investment requests and business opportunity assessments to optimize value creation across evolving tumor markets
Guide and develop Directors/Associate Directors, maintain trusted partnerships with clinical, commercial and strategy leaders, and influence senior stakeholders across OBU and Oncology R&D without formal authority
Qualification
Required
MBA or PhD
10+ years in biopharmaceuticals or related fields
Extensive experience in oncology
Strong consultative and communication skills
A strong scientific background and strategic analytical skills
Proven experience in pharmaceutical industry or consulting in which you have inputted to global pipeline strategy (market assessment, competitor analysis, forecasting)
Excellent analysis and fact-based decision-making
Experience with data and/or a science research/ bio-pharmaceutical environment
Highly intellectually capable with agility and adaptability
Motivated by working in a fast-paced field with clear societal impact
Understanding of general business and core marketing principles and application to future healthcare market challenges
Familiar with the oncology drug development process and necessary strategic and commercial touch points
Able to influence without authority and establish and maintain credibility with senior audiences
Resourceful, motivated, decisive and proactive; must be able to manage multiple priorities in a fast-growing organization
Attention to detail but also a big picture thinker & communicator
A critical thinker with experience of identifying and driving key projects and providing researched, verified, relevant information to leaders
Preferred
PhD in life sciences
Experience of setting up short- and long-term strategic plans
Understanding of clinical data and clinical trial design
Experience in at least two major geographies (e.g. US, EU, Japan, China)
Thorough understanding of regulatory and pricing dynamics in major markets
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program
Retirement contribution
Commission payment eligibility
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
Essential Business
2026-01-24
2026-01-23
Company data provided by crunchbase